Experiencia en el manejo de feocromocitoma en los últimos 10 años: serie de casos
PDF (Español (España))
HTML (Español (España))

Keywords

feocromocitoma
paranganglioma
tumores adrenales

How to Cite

Navarro, E. P., Osejo, M. C., Casas, L. Ángela, Arango, L. G., & Guzmán, G. (2017). Experiencia en el manejo de feocromocitoma en los últimos 10 años: serie de casos. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, 3(3), 33–36. https://doi.org/10.53853/encr.3.3.39

Abstract

El feocromocitoma es un tumor productor de catecolaminas. Se describe la experiencia en el diagnóstico, manejo y seguimiento de pacientes con este diagnóstico en una institución de alta complejidad en Cali, Colombia, en los últimos 10 años. Se encontraron 11 casos con diagnóstico de feocromocitoma llevados a cirugía, dos de estos extraadrenal y uno maligno. Fueron asintomáticos 18%, 81% presentaron hipertensión arterial. La evolución posquirúrgica de los pacientes fue favorable, 33% persistieron con hipertensión arterial (HTA) luego de la resección del tumor, requiriendo menor dosis de antihipertensivos. El único caso de malignidad tuvo una respuesta no satisfactoria. A pesar de ser un diagnóstico infrecuente, su abordaje es importante debido a la morbilidad que representa. Las características de nuestra población son similares a lo reportado en la literatura, con baja frecuencia de complicaciones y adecuada respuesta al tratamiento.

Abstract
Pheochromocytoma is a catecholamine-producing tumor. We describe the experience in the diagnosis, management and monitoring of patients with pheochromocytoma in a highly complex institution in Cali, Colombia, in the last 10 years. We identified 11 cases with diagnosis of pheochromocytoma, who were taken to surgery, being two of these extraadrenal and one of these malignant. 18% were asymptomatic, 81% had hypertension. The postoperative course of patients was favorable, 33% persisted hypertensive after tumor resection, although less doses of blood pressure medication were required. The only case of malignancy had an unsatisfactory response. Despite being a rare diagnosis, the approach is important because morbidity in our population is similar to those reported in the literature, with a low frequency of complications and adequate response to treatment.

https://doi.org/10.53853/encr.3.3.39
PDF (Español (España))
HTML (Español (España))

References

1. Lenders J, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet [Internet]. 2005; Available from: http://linkinghub.elsevier.com/retrieve/ pii/S0140673605671395\npapers2://publication/uuid/05CB9BF0- B7B4-4459-A95F-EB86E48D8365.
2. Manger WM, Gifford RW. Pheochromocytoma. J Clin Hypertens [Inter- net]. 2002;4(1):62–72. Available from: http://www.ncbi.nlm.nih.gov/ entrez/ query.fcgi?cmd=Retrieve&db =Pu bMed&dop t=Cit ation&l ist _ uids=11821644.
3. D´Achiardi R, Torres H, Guzmán J, Ordoñez JD. Feocromocitoma: presentación de seis casos. Acta Médica Colomb. 1980;5(3):453–63.
4. Shlomo Nelmed, Keneth Polonsky, P. Reed Larsen HMK. Williams Textbook of Endocrinology. 12th ed. Saunders E, editor. 2011. 548-549.
5. Castilho LN, Simoes F a, Santos a M, Rodrigues TM, Dos Santos Jr. C a. Pheo- chromocytoma: A long-term follow-up of 24 patients undergoing laparoscopic adrenalectomy. Int Braz J Urol [Internet]. 2009;35:24–31. Available from: http://www.embase.com/search/results?subaction=viewrecord&fr om=export&id=L354826797.
6. Plouin PF, Chatellier G, Fofol I, Corvol P. Tumor recurrence and hypertension persistence after successful pheochromocytoma operation. Hypertension [Internet]. 1997;29(5):1133–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9149678\n http://hyper.ahajournals.org.ezp-prod1.hul. harvard.edu/cgi/content/full/29/5/1133.
7. Edstr??m Elder E, Skog AHH, H????g A, Hamberger B. The management of benign and malignant pheochromocytoma and abdominal paraganglioma. Eur J Surg Oncol. 2003;29(3):278–83.
8. Shao Y, Chen R, Shen Z, Teng Y, Huang P, Rui W, et al. Preoperative alpha blockade for normotensive pheochromocytoma: is it necessary? J Hypertens [Internet]. 2011;29(12):2429–32. Available from: http://www.ncbi. nlm.nih.gov/pubmed/22025238.
9. Kiernan CM, Du L, Chen X, Broome JT, Shi C, Peters MF, et al. Predictors of hemodynamic instability during surgery for pheochromocytoma. Ann Surg Oncol [Internet]. 2014;21(12):3865–71. Available from: http://www.ncbi. nlm.nih.gov/pubmed/24939623.
10. Weingarten TN, Cata JP, O’Hara JF, Prybilla DJ, Pike TL, Thompson GB, et al. Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma. Urology. 2010;76(2):508.
11. Namekawa T1, Utsumi T2 KK. Clinical predictors of prolonged postresection hypotension after laparoscopic adrenalectomy for pheochromocytoma. Surgery. 2016;159(3):763–70.
12. Eisenhofer G, Bornstein SR, Brouwers FM, Cheung NK V, Dahia PL, De Krijger RR, et al. Malignant pheochromocytoma: Current status and initiatives for future progress. Endocrine-Related Cancer. 2004. p. 423–36.
13. Huang KH, Chung SD, Chen SC, Chueh SC, Pu YS, Lai MK, et al. Clinical and pathological data of 10 malignant pheochromocytomas: Long-term follow up in a single institute. Int J Urol. 2007;14(3):181–5.

Authors must state that they reviewed, validated and approved the manuscript's publication.  Moreover, they must sign a model release that should be sent.  A copy may be reviewed here

Dimensions


PlumX


Downloads

Download data is not yet available.